BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37398932)

  • 21. MNX1-AS1, a c-Myc induced lncRNA, promotes the Warburg effect by regulating PKM2 nuclear translocation.
    Wu Y; Wang Y; Yao H; Li H; Meng F; Li Q; Lin X; Liu L
    J Exp Clin Cancer Res; 2022 Dec; 41(1):337. PubMed ID: 36476366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c-myc/hexokinase 2 pathway.
    Yu Q; Dai W; Ji J; Wu L; Feng J; Li J; Zheng Y; Li Y; Cheng Z; Zhang J; Wu J; Xu X; Guo C
    J Cell Mol Med; 2022 May; 26(10):3031-3045. PubMed ID: 35429101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
    Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Function of m
    Yang S; Zhou D; Zhang C; Xiang J; Xi X
    Cancer Biol Ther; 2023 Dec; 24(1):2263921. PubMed ID: 37800580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
    Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
    J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
    Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
    Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
    Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the Expression Patterns and Potential Prognostic Role of 5-Methylcytosine Regulators in Hepatocellular Carcinoma.
    Liu Y; Zheng S; Wang T; Fang Z; Kong J; Liu J
    Front Cell Dev Biol; 2022; 10():842220. PubMed ID: 35252205
    [No Abstract]   [Full Text] [Related]  

  • 29. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
    Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
    J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human NOP2/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C/D snoRNPs.
    Liao H; Gaur A; McConie H; Shekar A; Wang K; Chang JT; Breton G; Denicourt C
    Nucleic Acids Res; 2022 Oct; 50(18):10695-10716. PubMed ID: 36161484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
    Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
    Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma.
    Li J; Hu ZQ; Yu SY; Mao L; Zhou ZJ; Wang PC; Gong Y; Su S; Zhou J; Fan J; Zhou SL; Huang XW
    Cancer Res; 2022 Mar; 82(6):1055-1069. PubMed ID: 35045986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation.
    Miao B; Wei C; Qiao Z; Han W; Chai X; Lu J; Gao C; Dong R; Gao D; Huang C; Ke A; Zhou J; Fan J; Shi G; Lan F; Cai J
    Am J Cancer Res; 2019; 9(5):1079-1090. PubMed ID: 31218114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct 5-methylcytosine profiles of circular RNA in human hepatocellular carcinoma.
    He Y; Zhang Q; Zheng Q; Yu X; Guo W
    Am J Transl Res; 2020; 12(9):5719-5729. PubMed ID: 33042451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis-Driven Hepatocarcinogenesis via ERK-Dependent PKM2 Nuclear Relocalization and Activation.
    Wong TL; Ng KY; Tan KV; Chan LH; Zhou L; Che N; Hoo RLC; Lee TK; Richard S; Lo CM; Man K; Khong PL; Ma S
    Hepatology; 2020 Apr; 71(4):1279-1296. PubMed ID: 31469916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.